New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—
Sep '25 Mar '25 Sep '24 Mar '24 Older periods
Current Ratio
8.09 11.04 0.64 0.09

+8 more quarters

Net Debt/EBITDA
4.78 — 1.70 —
Debt/Equity
0.00 0.00 0.00 —
Free Cash Flow per Share
— — — 0.00
Book value per Share
50.07 — (224.12) —
Free Cash Flow
(2.03) — (1.52) (2.95)
Other line items

Show all line items

Columns are period end dates